BBTX · smart money activity

Who's buying Bambusa Therapeutics, Inc.?

Bambusa Therapeutics, Inc. has 1 recent smart-money filing on record (Form 4), the latest on Nov 2, 2026.

Smart money score Score and rank in Pro

Latest filingNov 2, 2026

Independent buyers1

Signal sourcesForm 4

Insiders' avg buy price Pro

BBTX insider buying, 13F and 13D filings

Filed Nov 2, 2026Form 4 · 10% owner

Salvia Investment GmbH / Helmut Wolfgang Jeggle (Director) (10% owner): Bought $6.0M on the open market

View the filing on SEC EDGAR ↗

BBTX's score and rank are in Pro, with alerts when the next filing lands.

Try Pro free for 7 days

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.